Table 1.
Cells types that have been investigated for their potential to promote cardiac repair using BLI
| Cell Type | Information Gained from BLI | References |
|---|---|---|
| Bone marrow mononuclear cells | Comparison of different cell types for treatment of MI | 83 |
| Timing of cell delivery on acute vs. chronic MI | 76 | |
| Systemic homing to injured heart | 72 | |
| Adipose tissue-derived stem cells (ASCs) | Long-term survival of cells in injured heart | 3 |
| Homing and survival of fresh versus cultured cells to injured heart | 4 | |
| Mesenchymal stem cells (MSCs) | Comparison of ASCs vs. MSCs for treatment of MI | 82 |
| Growth factor-treated MSCs for treatment of MI | 24 | |
| Human CD34+ cells | Cell fate in the heart using a MI model | 89 |
| Rat cardiomyoblasts | Improvement of engraftment and survival with collagen matrix | 38, 39 |
| Embryonic stem cells | Cell survival, proliferation, and migration | 9, 42, 77 |
| Skeletal myoblasts | Cell fate in MI model | 83 |
| ESC-derived endothelial cells (ESC-EC) | Cell fate in MI model | 44, 45 |
| Effects of nicotine on the therapeutic effects ESC-ECs | 98 | |
| Resident cardiac stem cells | Cell fate and function in MI model | 43 |
BLI, bioluminescence imaging; MI, myocardial infarction.